Skip to main content
# Title Department Research Year
261 Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors 2021
262 Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells Department of Industrial Pharmacy 2021
263 The protein tyrosine phosphatase SHP-1 (PTPN-6) but not CD45 (PTPR-C) is essential for the ligand-mediated regulation of CD22 in BCR-ligated B cells Department of Pharmaceutical Organic Chemistry 2021
264 Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines Department of Pharmaceutics 2021
265 Enhanced molecular imprinted electrochemical sensing of histamine based on signal reporting nanohybrid Department of Pharmaceutical Organic Chemistry 2021
266 Untargeted Analysis of Lemna minor Metabolites: Workflow and Prioritization Strategy Comparing Highly Confident Features between Different Mass Spectrometers Department of Pharmacognosy 2021
267 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo Department of Industrial Pharmacy 2021
268 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
269 A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice Department of Pharmacology 2021
270 Indirect Differential Pulse Voltammetric Determination of Fluoride Ions at Carbon Paste Electrode Modified with Porous and Electroactive Fe3+/Fe2+ Based-Metal Organic Frameworks Type MIL-101(Fe) Department of Pharmaceutical Analytical Chemistry 2021